Related Experiment Video
Updated: Feb 15, 2026

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria
Published on: September 16, 2013
Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria
Karuna Gokarn1,2, Ramprasad B Pal1
1Department of Microbiology, Sir Hurkisondas Nurrotumdas Medical Research Society.
Abstract:
Infections by drug-resistant bacteria are life-threatening. As iron is a vital element for the growth of bacteria, iron-chelating agents (siderophores) can be used to arrest their multiplication. Exogenous siderophores - exochelin-MS and deferoxamine-B - were evaluated for their inhibitory activity against methicillin-resistant Staphylococcus aureus and metallo-β-lactamase producers - Pseudomonas aeruginosa and Acinetobacter baumannii - by disc diffusion, micro-broth dilution, and turbidimetric growth assays. The drug-resistant isolates were inhibited by the synergistic activity of siderophores and antibiotics. Minimum inhibitory concentration of exochelin-MS+ampicillin for different isolates was between 0.05 and 0.5 mg/mL. Minimum inhibitory concentration of deferoxamine-B+ampicillin was 1.0 mg/mL and greater. Iron-chelation therapy could provide a complementary approach to overcome drug resistance in pathogenic bacteria.
Insights
Iron-chelating siderophores, exochelin-MS and deferoxamine-B, show promise in combating drug-resistant bacteria like MRSA and MDR Gram-negatives. Their combination with antibiotics effectively inhibits bacterial growth, offering a new strategy against antimicrobial resistance.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Drug-resistant bacterial infections pose a significant global health threat.
- Iron is essential for bacterial growth, making iron-chelating agents (siderophores) potential antimicrobial agents.
- Specific drug-resistant pathogens include methicillin-resistant Staphylococcus aureus (MRSA) and metallo-β-lactamase (MBL) producing Pseudomonas aeruginosa and Acinetobacter baumannii.
Purpose of the Study:
- To evaluate the inhibitory activity of exogenous siderophores, exochelin-MS and deferoxamine-B, against key drug-resistant bacteria.
- To assess the synergistic effects of these siderophores when combined with antibiotics.
- To explore iron-chelation therapy as a complementary strategy against bacterial drug resistance.
Main Methods:
- Disc diffusion assays
- Micro-broth dilution assays
- Turbidimetric growth assays
- Testing against MRSA, P. aeruginosa, and A. baumannii isolates
Main Results:
- Siderophores exochelin-MS and deferoxamine-B demonstrated inhibitory activity against the tested drug-resistant bacteria.
- Synergistic effects were observed when siderophores were combined with antibiotics, enhancing bacterial inhibition.
- Minimum inhibitory concentrations (MICs) for exochelin-MS + ampicillin ranged from 0.05 to 0.5 mg/mL.
- MICs for deferoxamine-B + ampicillin were 1.0 mg/mL or higher.
Conclusions:
- Exogenous siderophores exhibit antimicrobial activity against important drug-resistant pathogens.
- Combining siderophores with antibiotics offers a synergistic approach to overcome bacterial drug resistance.
- Iron-chelation therapy represents a promising complementary strategy to combat life-threatening infections caused by multidrug-resistant bacteria.
More Related Videos
Related Concept Videos
Gram-negative Bacterial Protein Secretion Systems
Positive, Negative, and Zero Work
Positive and Negative Feedback Loops
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Negative Regulator Molecules
Position-effect Variegation

